The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1696-1703

  Buschart, Anna ^a   Burakowska, Anna ^a,b   Bilitewski, Ursula ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; FLUCONAZOLE; FLUDIOXONIL; FUNGICIDE; PROTEIN HISTIDINE KINASE; PROTEIN NIK1P; RHODAMINE 6G; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; DRUG ANTAGONISM; FUNGAL GENE; FUNGUS GROWTH; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; DIOXOLES; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; FUNGICIDES, INDUSTRIAL; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PROTEIN KINASES; PYRROLES; RHODAMINES;

EID: 84869475919     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.050963-0     Document Type: Article

References (49)

1. Alex, L. A., Korch, C., Selitrennikoff, C. P. & Simon, M. I. (1998). COS1, a two-component histidine kinase that is involved in hyphal development in the opportunistic pathogen Candida albicans. Proc Natl Acad Sci U S A 95, 7069-7073.
2. Arnaud, M. B., Inglis, D. O., Skrzypek, M. S., Binkley, J., Shah, P., Binkley, G., Miyasato, S. R., Simison, M. & Sherlock, G. (2012). Candida Genome Database [accessed 17 April 2012]. http://www. candidagenome.org/
3. Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193.
4. Buschart, A., Gremmer, K., El-Mowafy, M., van den Heuvel, J., Mueller, P. P. & Bilitewski, U. (2012). A novel functional assay for fungal histidine kinases group III reveals the role of HAMP domains for fungicide sensitivity. J Biotechnol 157, 268-277.
5. Calderone, R. A. & Fonzi, W. A. (2001). Virulence factors of Candida albicans. Trends Microbiol 9, 327-335.
6. Chauhan, N. & Calderone, R. (2008). Two-component signal transduction proteins as potential drug targets in medically important fungi. Infect Immun 76, 4795-4803.
7. Chauhan, N., Kruppa, M. & Calderone, R. (2007). The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole. Antimicrob Agents Chemother 51, 3747-3751.
8. Coste, A. T., Karababa, M., Ischer, F., Bille, J. & Sanglard, D. (2004). TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3, 1639-1652.
9. Coste, A., Turner, V., Ischer, F., Morschhä user, J., Forche, A., Selmecki, A., Berman, J., Bille, J. & Sanglard, D. (2006). A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172, 2139-2156.
10. Dogra, S., Krishnamurthy, S., Gupta, V., Dixit, B. L., Gupta, C. M., Sanglard, D. & Prasad, R. (1999). Asymmetric distribution of phosphatidylethanolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15, 111-121.
11. EFR (2012). Fludioxonil; tolerances for residues. Electronic Code of Federal Regulations. Title 40: Protection of Environment, Part 180-Tolerances and exemptions for pesticide chemical residues in food, Subpart C-Specific Tolerances, section §180.516. http://www.gpo. gov/fdsys/
12. EUCAST (2008). EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14, 398-405.
13. European Commission (2011). Commission Regulation (EU) No 813/2011 of 11 August 2011 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acequinocyl, emamectin benzoate, ethametsulfuron-methyl, flubendiamide, fludioxonil, kresoxim-methyl, methoxyfenozide, novaluron, thiacloprid and trifloxystrobin in or on certain products. Official Journal of the European Union 54, L208/23.
14. Fournier, P., Schwebel, C., Maubon, D., Vesin, A., Lebeau, B., Foroni, L., Hamidfar-Roy, R., Cornet, M., Timsit, J. F. & Pelloux, H. (2011). Antifungal use influences Candida species distribution and susceptibility in the intensive care unit. J Antimicrob Chemother 66, 2880-2886.
15. Gaur, M., Choudhury, D. & Prasad, R. (2005). Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol 9, 3-15.
16. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y. & other authors (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5, R80.
17. Gillum, A. M., Tsay, E. Y. & Kirsch, D. R. (1984). Isolation of the Candida albicans gene for orotidine-59-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198, 179-182.
18. Homann, O. R., Dea, J., Noble, S. M. & Johnson, A. D. (2009). A phenotypic profile of the Candida albicans regulatory network. PLoS Genet 5, e1000783.
19. Inglis, D. O., Arnaud, M. B., Binkley, J., Shah, P., Skrzypek, M. S., Wymore, F., Binkley, G., Miyasato, S. R., Simison, M. & Sherlock, G. (2012). The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res 40 (Database issue), D667-D674.
20. Krishnamurthy, S., Gupta, V., Snehlata, P. & Prasad, R. (1998a). Characterisation of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family. FEMS Microbiol Lett 158, 69-74.
21. Krishnamurthy, S., Gupta, V., Prasad, R., Panwar, S. L. & Prasad, R. (1998b). Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol Lett 160, 191-197.
22. Liu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R. & Rogers, P. D. (2005). Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49, 2226-2236.
23. Maesaki, S., Marichal, P., Vanden Bossche, H., Sanglard, D. & Kohno, S. (1999). Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother 44, 27-31.
24. Nobile, C. J. & Mitchell, A. P. (2009). Large-scale gene disruption using the UAU1 cassette. Methods Mol Biol 499, 175-194.
25. Ochiai, N., Fujimura, M., Oshima, M., Motoyama, T., Ichiishi, A., Yamada-Okabe, H. & Yamaguchi, I. (2002). Effects of iprodione and fludioxonil on glycerol synthesis and hyphal development in Candida albicans. Biosci Biotechnol Biochem 66, 2209-2215.
26. Okada, A., Banno, S., Ichiishi, A., Rimura, M., Yamaguchi, I. & Fujimura, M. (2005). Pyrrolnitrin interferes with osmotic signal transduction in Neurospora crassa. J Pestic Sci 30, 378-383.
27. Pfaller, M. A. & Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20, 133-163.
28. Pillonel, C. & Meyer, T. (1997). Effect of phenylpyrroles on glycerol accumulation and protein kinase activity of Neurospora crassa. Pestic Sci 49, 229-236.
29. Prasad, R., De Wergifosse, P., Goffeau, A. & Balzi, E. (1995). Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27, 320-329.
30. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39, 1-8.
31. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39, 2378-2386.
32. Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40, 2300-2305.
33. Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1997). Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416.
34. Sanglard, D. & Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85.
35. Schmidt, M., Barker, S., Essmann, M. & Larsen, B. (2008). Effect of commonly used herbicides on the virulence factor CDR1 in Candida albicans. Environ Toxicol Chem 27, 2346-2351.
36. Shukla, S., Rai, V., Saini, P., Banerjee, D., Menon, A. K. & Prasad, R. (2007). Candida drug resistance protein 1, a major multidrug ATP binding cassette transporter of Candida albicans, translocates fluorescent phospholipids in a reconstituted system. Biochemistry 46, 12081-12090.
37. Shukla, S., Yadav, V., Mukhopadhyay, G. & Prasad, R. (2011). Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell 10, 1357-1366.
38. Siikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P. & Sanglard, D. (2010). Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 65, 2505-2513.
39. Sipos, G. & Kuchler, K. (2006). Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification. Curr Drug Targets 7, 471-481.
40. Smriti, K., Krishnamurthy, S., Dixit, B. L., Gupta, C. M., Milewski, S. & Prasad, R. (2002). ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19, 303-318.
41. Smyth, G. K. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3.
42. Smyth, G. K. & Speed, T. (2003). Normalization of cDNA microarray data. Methods 31, 265-273.
43. Staab, J. F., Ferrer, C. A. & Sundstrom, P. (1996). Developmental expression of a tandemly repeated, proline-and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. J Biol Chem 271, 6298-6305.
44. Staab, J. F. & Sundstrom, P. (1998). Genetic organization and sequence analysis of the hypha-specific cell wall protein gene HWP1 of Candida albicans. Yeast 14, 681-686.
45. Tanabe, K., Lamping, E., Nagi, M., Okawada, A., Holmes, A. R., Miyazaki, Y., Cannon, R. D., Monk, B. C. & Niimi, M. (2011). Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function. MolMicrobiol 82, 416-433.
46. Tsao, S., Rahkhoodaee, F. & Raymond, M. (2009). Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Chemother 53, 1344-1352.
47. Wesolowski, J., Hassan, R. Y. A., Reinhardt, K., Hodde, S. & Bilitewski, U. (2010). Antifungal compounds redirect metabolic pathways in yeasts: metabolites as indicators of modes of action. J Appl Microbiol 108, 462-471.
48. Wirsching, S., Michel, S. & Morschhä user, J. (2000). Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36, 856-865.
49. Yamada-Okabe, T., Mio, T., Ono, N., Kashima, Y., Matsui, M., Arisawa, M. & Yamada-Okabe, H. (1999). Roles of three histidine kinase genes in hyphal development and virulence of the pathogenic fungus Candida albicans. J Bacteriol 181, 7243-7247.